Incidence of and risk factors for genital human papillomavirus infection in women drug users

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 527-529

  Dev, Deepti ^a   Lo, Yungtai ^a   Ho, Gloria Y F ^a   Burk, Robert D ^a   Klein, Robert S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Drug users; Human papillomavirus; Women

Indexed keywords

ADULT; ARTICLE; CONDOM; DRUG DEPENDENCE; FEMALE; GENITAL TRACT INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; ETHNIC GROUPS; FEMALE; GENITAL DISEASES, FEMALE; GENOTYPE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; INTERVIEWS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; VAGINA;

EID: 33646782949     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000186372.02925.4b     Document Type: Article

References (17)

1. Munõz N, Bosch FX, Shah KV, et al, eds. The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon: International Agency for Research on Cancer;1992.
2. Hines JF, Jenson AB, Barnes WA.Human papillomaviruses: their clinical significance in the management of cervical carcinoma. Oncology. 1995;9:279-288.
3. Bosch FX, Manos M, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87:796-802.
4. Halpert R, Fruchter RG, Sedlis A, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol. 1986;68:251-258.
5. Henry MJ, Stanley MW, Cruikshank S, et al. Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1989;160:352-353.
6. Schafer A, Friedman W, Mielke M, et al. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol. 1991;164:593-599.
7. Vermund SH, Kelly KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol. 1991;165:392-400.
8. Center for Disease Control. 1993 Sexually transmitted diseases treatment guidelines. Morbid Mortal Wkly Rep. 1993;42(RR-14):1-102.
9. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med. 1992;327:1697-1703.
10. Ahdieh L, Klein RS, Burk RD, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682-690.
11. Laga M, Icenogle JP, Marsella R, et al. Genital papillomavirus infection and cervical dysplasia: opportunistic complications of HIV infection. Int J Cancer. 1992;50:45-48.
12. Palefsky JM, Mindoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high risk HIV-negative women. J Natl Cancer Inst. 1999;91:226-236.
13. Jamieson DJ, Duerr A, Burk RD, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol. 2002;186:21-27.
14. Ho GY, Burk RD, Fleming I, et al. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer. 1994;56:788-792.
15. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst. 1991;83:997-1003.
16. Klein RS, Ho GYF, Vermund SH, et al. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis. 1994;170:1404-1409.
17. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365-1371.